• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当前对肌肉减少症的认识:调节肌肉质量的可能因素。

Current understanding of sarcopenia: possible candidates modulating muscle mass.

作者信息

Sakuma Kunihiro, Aoi Wataru, Yamaguchi Akihiko

机构信息

Research Center for Physical Fitness, Sports and Health, Toyohashi University of Technology, 1-1 Hibarigaoka, Tenpaku-cho, Toyohashi, 441-8580, Japan,

出版信息

Pflugers Arch. 2015 Feb;467(2):213-29. doi: 10.1007/s00424-014-1527-x. Epub 2014 May 7.

DOI:10.1007/s00424-014-1527-x
PMID:24797147
Abstract

The world's elderly population is expanding rapidly, and we are now faced with the significant challenge of maintaining or improving physical activity, independence, and quality of life in the elderly. Sarcopenia, the age-related loss of skeletal muscle mass, is characterized by a deterioration of muscle quantity and quality leading to a gradual slowing of movement, a decline in strength and power, increased risk of fall-related injury, and often, frailty. Since sarcopenia is largely attributed to various molecular mediators affecting fiber size, mitochondrial homeostasis, and apoptosis, the mechanisms responsible for these deleterious changes present numerous therapeutic targets for drug discovery. Muscle loss has been linked with several proteolytic systems, including the ubuiquitin-proteasome, lysosome-autophagy, and tumor necrosis factor (TNF)-α/nuclear factor-kappaB (NF-κB) systems. Although many factors are considered to regulate age-dependent muscle loss, this gentle atrophy is not affected by factors known to enhance rapid atrophy (denervation, hindlimb suspension, etc.). In addition, defects in Akt-mammalian target of rapamycin (mTOR) and serum response factor (SRF)-dependent signaling have been found in sarcopenic muscle. Intriguingly, more recent studies indicated an apparent functional defect in autophagy- and myostatin-dependent signaling in sarcopenic muscle. In this review, we summarize the current understanding of the adaptation of many regulators in sarcopenia.

摘要

全球老年人口正在迅速增长,我们现在面临着一项重大挑战,即维持或改善老年人的身体活动、独立性和生活质量。肌肉减少症是与年龄相关的骨骼肌质量流失,其特征是肌肉数量和质量下降,导致运动逐渐减慢、力量和功率下降、跌倒相关损伤风险增加,并且常常伴有身体虚弱。由于肌肉减少症很大程度上归因于影响纤维大小、线粒体稳态和细胞凋亡的各种分子介质,这些有害变化的机制为药物研发提供了众多治疗靶点。肌肉流失与多种蛋白水解系统有关,包括泛素-蛋白酶体系统、溶酶体-自噬系统和肿瘤坏死因子(TNF)-α/核因子-κB(NF-κB)系统。尽管许多因素被认为可调节年龄依赖性肌肉流失,但这种轻度萎缩不受已知会加剧快速萎缩的因素(去神经支配、后肢悬吊等)影响。此外,在肌肉减少症患者的肌肉中发现了Akt-雷帕霉素哺乳动物靶蛋白(mTOR)和血清反应因子(SRF)依赖性信号通路的缺陷。有趣的是,最近的研究表明,在肌肉减少症患者的肌肉中,自噬和肌肉生长抑制素依赖性信号通路存在明显的功能缺陷。在这篇综述中,我们总结了目前对肌肉减少症中许多调节因子适应性的理解。

相似文献

1
Current understanding of sarcopenia: possible candidates modulating muscle mass.当前对肌肉减少症的认识:调节肌肉质量的可能因素。
Pflugers Arch. 2015 Feb;467(2):213-29. doi: 10.1007/s00424-014-1527-x. Epub 2014 May 7.
2
Molecular mechanisms in aging and current strategies to counteract sarcopenia.衰老的分子机制及当前对抗肌肉减少症的策略。
Curr Aging Sci. 2010 Jul;3(2):90-101. doi: 10.2174/1874609811003020090.
3
Molecular mechanism of sarcopenia and cachexia: recent research advances.肌肉减少症和恶病质的分子机制:最新研究进展
Pflugers Arch. 2017 Jun;469(5-6):573-591. doi: 10.1007/s00424-016-1933-3. Epub 2017 Jan 19.
4
Novel intriguing strategies attenuating to sarcopenia.减轻肌肉减少症的新型有趣策略。
J Aging Res. 2012;2012:251217. doi: 10.1155/2012/251217. Epub 2012 Feb 20.
5
Sarcopenia and age-related endocrine function.肌肉减少症与年龄相关的内分泌功能。
Int J Endocrinol. 2012;2012:127362. doi: 10.1155/2012/127362. Epub 2012 May 28.
6
Overweight in elderly people induces impaired autophagy in skeletal muscle.老年人超重会导致骨骼肌自噬受损。
Free Radic Biol Med. 2017 Sep;110:31-41. doi: 10.1016/j.freeradbiomed.2017.05.018. Epub 2017 May 23.
7
The Role of Nutrition in Attenuating Age-Related Skeletal Muscle Atrophy.营养在减轻与年龄相关的骨骼肌萎缩中的作用。
Adv Exp Med Biol. 2020;1260:297-318. doi: 10.1007/978-3-030-42667-5_12.
8
Recent advances in pharmacological, hormonal, and nutritional intervention for sarcopenia.肌肉减少症的药理学、激素和营养干预的最新进展。
Pflugers Arch. 2018 Mar;470(3):449-460. doi: 10.1007/s00424-017-2077-9. Epub 2017 Oct 18.
9
Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials.衰老相关的线粒体功能障碍与肌肉减少症:从信号通路到临床试验。
Int J Biochem Cell Biol. 2013 Oct;45(10):2288-301. doi: 10.1016/j.biocel.2013.06.024. Epub 2013 Jul 8.
10
The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials.肌少症性肥胖中肌肉生长抑制素信号传导的恶性循环:肌肉生长抑制素在骨骼肌生长、胰岛素信号传导中的作用及对临床试验的影响
J Frailty Aging. 2018;7(1):21-27. doi: 10.14283/jfa.2017.33.

引用本文的文献

1
Longitudinal changes of body composition during a 3-year follow-up in Taiwan adults with type 2 diabetes.台湾2型糖尿病成年患者3年随访期间身体成分的纵向变化。
BMJ Nutr Prev Health. 2025 Jun 18;8(1):e000995. doi: 10.1136/bmjnph-2024-000995. eCollection 2025.
2
A Liposomal Strategy for Dual-Action Therapy in Sarcopenia: Co-Delivery of Caffeine and HAMA.一种用于少肌症双效治疗的脂质体策略:咖啡因与透明质酸微球的共递送
Int J Mol Sci. 2025 Jun 24;26(13):6031. doi: 10.3390/ijms26136031.
3
Plasma Extracellular Vesicles Biomarkers Linked to Lower Muscle Mass, Function and Physical Performance in Sarcopenia.

本文引用的文献

1
Myostatin and sarcopenia: opportunities and challenges - a mini-review.肌肉生长抑制素与肌肉减少症:机遇与挑战——一篇综述短文
Gerontology. 2014;60(4):289-93. doi: 10.1159/000356740. Epub 2014 Jan 17.
2
Skeletal muscle, autophagy, and physical activity: the ménage à trois of metabolic regulation in health and disease.骨骼肌、自噬和体力活动:代谢调节在健康和疾病中的三位一体。
J Mol Med (Berl). 2014 Feb;92(2):127-37. doi: 10.1007/s00109-013-1096-z. Epub 2013 Nov 24.
3
Skeletal muscle autophagy: a new metabolic regulator.骨骼肌自噬:一种新的代谢调节剂。
与肌肉减少症中较低肌肉质量、功能和身体表现相关的血浆细胞外囊泡生物标志物
J Cachexia Sarcopenia Muscle. 2025 Apr;16(2):e13784. doi: 10.1002/jcsm.13784.
4
Acute Sarcopenia: Mechanisms and Management.急性肌肉减少症:机制与管理。
Nutrients. 2024 Oct 10;16(20):3428. doi: 10.3390/nu16203428.
5
Age-related differences in the loss and recovery of serial sarcomere number following disuse atrophy in rats.年龄相关的大鼠废用性萎缩后串联肌节数量丢失和恢复的差异。
Skelet Muscle. 2024 Aug 2;14(1):18. doi: 10.1186/s13395-024-00351-5.
6
Exploring the metabolomics profile of frailty- a systematic review.探索衰弱的代谢组学特征——一项系统综述
J Diabetes Metab Disord. 2024 Jan 13;23(1):289-303. doi: 10.1007/s40200-023-01379-y. eCollection 2024 Jun.
7
Association of dietary patterns with sarcopenia in adults aged 50 years and older.饮食模式与 50 岁及以上成年人肌少症的关系。
Eur J Nutr. 2024 Aug;63(5):1651-1662. doi: 10.1007/s00394-024-03370-6. Epub 2024 Apr 3.
8
Therapeutic strategies to modulate gut microbial health: Approaches for sarcopenia management.调节肠道微生物健康的治疗策略:肌少症管理方法。
Histol Histopathol. 2024 Nov;39(11):1395-1425. doi: 10.14670/HH-18-730. Epub 2024 Mar 6.
9
The effectiveness of protein supplementation combined with resistance exercise programs among community-dwelling older adults with sarcopenia: a systematic review and meta-analysis.补充蛋白质联合抗阻运动方案对社区居住的伴有肌少症的老年人的有效性:系统评价和荟萃分析。
Epidemiol Health. 2024;46:e2024030. doi: 10.4178/epih.e2024030. Epub 2024 Feb 14.
10
Understanding the Consequences of Fatty Bone and Fatty Muscle: How the Osteosarcopenic Adiposity Phenotype Uncovers the Deterioration of Body Composition.了解脂肪骨和脂肪肌肉的后果:骨肌减少性肥胖表型如何揭示身体成分的恶化。
Metabolites. 2023 Oct 7;13(10):1056. doi: 10.3390/metabo13101056.
Trends Endocrinol Metab. 2013 Dec;24(12):635-43. doi: 10.1016/j.tem.2013.09.004. Epub 2013 Oct 29.
4
Maintenance of muscle mass and load-induced growth in Muscle RING Finger 1 null mice with age.随着年龄增长,肌肉环指蛋白1基因敲除小鼠肌肉质量的维持及负荷诱导的生长情况。
Aging Cell. 2014 Feb;13(1):92-101. doi: 10.1111/acel.12150. Epub 2013 Sep 12.
5
Selective autophagy: talking with the UPS.选择性自噬:与 UPS 对话。
Cell Biochem Biophys. 2013 Sep;67(1):3-13. doi: 10.1007/s12013-013-9623-7.
6
Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway.调控衰老骨骼肌质量的信号通路:IGF1-Akt-mTOR-FoxO 通路的作用。
Biogerontology. 2013 Jun;14(3):303-23. doi: 10.1007/s10522-013-9432-9. Epub 2013 May 19.
7
GSK-3α is a central regulator of age-related pathologies in mice.GSK-3α 是小鼠与年龄相关病理的核心调节因子。
J Clin Invest. 2013 Apr;123(4):1821-32. doi: 10.1172/JCI64398. Epub 2013 Mar 15.
8
Mechanisms regulating skeletal muscle growth and atrophy.调节骨骼肌生长和萎缩的机制。
FEBS J. 2013 Sep;280(17):4294-314. doi: 10.1111/febs.12253. Epub 2013 Apr 17.
9
Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy.在营养胁迫和自噬中,AMPK 对不同的 Vps34 复合物进行差异调节。
Cell. 2013 Jan 17;152(1-2):290-303. doi: 10.1016/j.cell.2012.12.016.
10
Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells.激活素 A-肌肉生长抑制素-卵泡抑素系统对衰老的骨和肌肉祖细胞的影响。
Exp Gerontol. 2013 Feb;48(2):290-7. doi: 10.1016/j.exger.2012.11.004. Epub 2012 Nov 21.